Evidence map›Paper›PMID 43015615›Full record

ArticleGenes & nutrition2026

Multi-study analysis reveals dynamic postprandial biomarkers for metabolic syndrome by low-level fusion of multi-platform data from nutritional challenge test studies.

Tim van den Broek, Jelle Cbc de Jong, Milena Rundle, Jarlei Fiamoncini, Yoana Kiselova-Kaneva, Martien Pm Caspers, Diana G Ivanova, Ben van Ommen, Jildau Bouwman, Suzan Wopereis

Abstract read
In one paragraph

Article in Genes & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tim van den Broek *Department of Microbiology and Systems Biology, The Netherlands Organization for Applied Scientific Research (TNO), PO BOX 2215, Leiden, 2301 CE, The Netherlands.
Jelle Cbc de Jong *Department of Microbiology and Systems Biology, The Netherlands Organization for Applied Scientific Research (TNO), PO BOX 2215, Leiden, 2301 CE, The Netherlands.
Milena RundleFaculty of Medicine, Department of Metabolism, Digestion and Reproduction, Nutrition and Dietetic Research Group, Imperial College London, London, UK.
Jarlei FiamonciniFood Research Center, Department of Food Science and Experimental Nutrition, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Yoana Kiselova-KanevaDepartment of Biochemistry, Molecular Medicine and Nutrigenomics, Medical University of Varna, Varna, Bulgaria.
Martien Pm CaspersDepartment of Microbiology and Systems Biology, The Netherlands Organization for Applied Scientific Research (TNO), PO BOX 2215, Leiden, 2301 CE, The Netherlands.
Diana G IvanovaDepartment of Biochemistry, Molecular Medicine and Nutrigenomics, Medical University of Varna, Varna, Bulgaria.
Ben van OmmenDepartment of Microbiology and Systems Biology, The Netherlands Organization for Applied Scientific Research (TNO), PO BOX 2215, Leiden, 2301 CE, The Netherlands.
Jildau BouwmanDepartment of Microbiology and Systems Biology, The Netherlands Organization for Applied Scientific Research (TNO), PO BOX 2215, Leiden, 2301 CE, The Netherlands.
Suzan WopereisDepartment of Microbiology and Systems Biology, The Netherlands Organization for Applied Scientific Research (TNO), PO BOX 2215, Leiden, 2301 CE, The Netherlands. suzan.wopereis@tno.nl.

Funding

EU 7th Framework KBBE-20115-289511
6 · The paper itself

Abstract

backgroundMetabolic syndrome (MetS) is a global health issue linked to increased disease risk and economic burden. Traditional biomarkers for MetS reflect disrupted homeostasis but may fail to detect earlier stages of imbalance, i.e., an increase in allostatic load. Health can be defined as the capacity to maintain or recover homeostatic control, and this capacity can be assessed via a standardized nutritional challenge test (e.g., PhenFlex), which provokes adaptive metabolic responses. We aimed to identify a biomarker signature indicative of MetS-associated allostatic load, using data from multiple nutritional challenge test (NCT) studies.

resultsA multi-study analysis was performed using data from four human studies with nutritional challenge test (n = 195). We identified 64 analytes with significantly altered postprandial responses in individuals with MetS (n = 78) compared to healthy controls (n = 117). Cluster analysis revealed four clusters with a distinct temporal dynamic response to the NCT. The most prominently affected analytes included total triacylglycerides, C-peptide, leptin, and a range of amino acids (e.g., L-glutamic acid, L-serine, and L-leucine). The response of a subset of these analytes to the nutritional challenge test also changed after a 12-week, 20% energy-restriction intervention in an independent trial (n = 72), supporting their potential as markers for monitoring intervention efficacy. Further network and ontology-based analyses revealed that the altered analytes represented key biological processes, particularly lipid and protein metabolism, as well as higher-level physiological function domains, such as liver, muscle, adipose tissue, and pancreas function. These domains were also responsive to the energy-restriction intervention.

conclusionsThis study identified a robust, dynamic biomarker signature for MetS that emerges in response to a NCT. This signature reflects increased allostatic load and highlights disrupted adaptability across multiple metabolic functions. A subset of the identified markers were modifiable through dietary intervention, supporting their potential as early, actionable biomarkers of metabolic health.

Indexed as

BiomarkersDiabetesMeta-analysisMetabolomicsMonitoringObesityPostprandial responsePrecision nutritionScreeningStratification

Identifiers

PMID43015615
PMCPMC13757235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.